Kathy Lyons

1.2k total citations
11 papers, 377 citations indexed

About

Kathy Lyons is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kathy Lyons has authored 11 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Oncology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kathy Lyons's work include Peptidase Inhibition and Analysis (5 papers), Diabetes Treatment and Management (5 papers) and Neuropeptides and Animal Physiology (5 papers). Kathy Lyons is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Diabetes Treatment and Management (5 papers) and Neuropeptides and Animal Physiology (5 papers). Kathy Lyons collaborates with scholars based in United States and United Kingdom. Kathy Lyons's co-authors include Julie A. DeMartino, Martin S. Springer, Dennis Feng, George J. Eiermann, Ann E. Weber, Tesfaye Biftu, Joseph K. Wu, Megan Mefford, Xiaoping Zhang and Steven M. Wolinsky and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Experimental Biology and Medicine.

In The Last Decade

Kathy Lyons

11 papers receiving 365 citations

Peers

Countries citing papers authored by Kathy Lyons

Since Specialization

Citations

This map shows the geographic impact of Kathy Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Lyons more than expected).

Fields of papers citing papers by Kathy Lyons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Lyons. The network helps show where Kathy Lyons may publish in the future.

Co-authorship network of co-authors of Kathy Lyons

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Lyons. A scholar is included among the top collaborators of Kathy Lyons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Lyons. Kathy Lyons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Assessment of Chloroquine Treatment for Modulating Autophagy Flux in Brain of WT and HD Mice 2014 ·Journal of Huntington s Disease ·Petr Vodička, Junghyun Lim, (unknown), Kimberly B. Kegel, Kathryn Chase, Hyunsun Park, Deanna M. Marchionini, (unknown), Tania Mead, Helen L. Birch, Dawn Yates, Kathy Lyons, Celia Dominguez, Maria Beconi, Zhenyu Yue, Neil Aronin, Marian DiFiglia	29
2	Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine (23) 2013 ·Bioorganic & Medicinal Chemistry Letters ·Tesfaye Biftu, Xiaoxia Qian, Ping Chen, Dennis Feng, Giovanna Scapin, Ying‐Duo Gao, Jason M. Cox, Ranabir Sinha Roy, George J. Eiermann, (unknown), Kathy Lyons, Gino Salituro, Sangita B. Patel, (unknown), Feng Xu, Shiyao Xu, Bei Zhang, Charles G. Caldwell, Joseph K. Wu, Ann E. Weber	29
3	Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome 2011 ·Bioorganic & Medicinal Chemistry Letters ·Milana Maletic, (unknown), Michael J. Szymonifka, Steven S. Mundt, Hratch J. Zokian, Kashmira Shah, Jasminka Dragovic, Kathy Lyons, Rolf Thieringer, (unknown), James M. Balkovec, Sherman T. Waddell	12
4	Substituted phenyl triazoles as selective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 2011 ·Bioorganic & Medicinal Chemistry Letters ·Wanying Sun, Milana Maletic, Steven S. Mundt, Kashmira Shah, Hratch J. Zokian, Kathy Lyons, Sherman T. Waddell, James M. Balkovec	11
5	CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates 2007 ·The Journal of Immunology ·Carsten Schröder, Richard N. Pierson, Bao-Ngoc Nguyen, D W Kawka, Laurence B. Peterson, Guosheng Wu, Tianshu Zhang, Martin S. Springer, (unknown), Susan A. Iliff, Julia M. Ayala, Min Lu, John S. Mudgett, Kathy Lyons, Sander G. Mills, Geraldine G. Miller, Irwin Singer, Agnes M. Azimzadeh, Julie A. DeMartino	48
6	Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes 2007 ·Bioorganic & Medicinal Chemistry Letters ·Gui‐Bai Liang, Xiaoxia Qian, Dennis Feng, Tesfaye Biftu, George J. Eiermann, Huaibing He, Barbara Leiting, Kathy Lyons, Aleksandr Petrov, Ranabir SinhaRoy, Bei Zhang, Joseph K. Wu, Xiaoping Zhang, Nancy A. Thornberry, Ann E. Weber	27
7	Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin 2007 ·Bioorganic & Medicinal Chemistry Letters ·Tesfaye Biftu, Giovanna Scapin, Suresh B. Singh, Dennis Feng, (unknown), George J. Eiermann, Huaibing He, Kathy Lyons, Sangita B. Patel, Aleksandr Petrov, Ranabir SinhaRoy, Bei Zhang, Joseph K. Wu, Xiaoping Zhang, George A. Doss, Nancy A. Thornberry, Ann E. Weber	51
8	(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes 2006 ·Bioorganic & Medicinal Chemistry Letters ·Tesfaye Biftu, Dennis Feng, Xiaoxia Qian, Gui‐Bai Liang, G. R. KIECZYKOWSKI, George J. Eiermann, Huaibing He, Barbara Leiting, Kathy Lyons, Aleksandr Petrov, Ranabir SinhaRoy, Bei Zhang, Giovanna Scapin, (unknown), Ying‐Duo Gao, Suresh B. Singh, Joseph K. Wu, Xiaoping Zhang, Nancy A. Thornberry, Ann E. Weber	34
9	101 2006 ·The Journal of Heart and Lung Transplantation ·Bao N. Nguyen, Agnes M. Azimzadeh, (unknown), Guosheng Wu, (unknown), Carsten Schroeder, Kathy Lyons, Irwin Singer, L. Peterson, Julie A. DeMartino, Richard N. Pierson	1
10	Inhibition of Dipeptidyl-Peptidase IV Does Not Increase Circulating IGF-1 Concentrations in Growing Pigs 2006 ·Experimental Biology and Medicine ·(unknown), Barbara Leiting, KellyAnn D. Pryor, Kathy Lyons, Gerard J. Hickey, D. R. Thompson	10
11	Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection 2003 ·The Journal of Experimental Medicine ·Ronald S. Veazey, Per Johan Klasse, Thomas J. Ketas, Jacqueline D. Reeves, Michael Piatak, Kevin Kunstman, Shawn E. Kuhmann, Preston A. Marx, Jeffrey D. Lifson, Jason Dufour, Megan Mefford, Ivona Pandrea, Steven M. Wolinsky, Robert W. Doms, Julie A. DeMartino, Salvatore Siciliano, Kathy Lyons, Martin S. Springer, John P. Moore	125

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact